We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAH icon
1876
Sonic Automotive
SAH
$3.15B
$204K ﹤0.01%
4,785
-597
-11% -$29.4K
ADPT icon
1877
Adaptive Biotechnologies
ADPT
$3.56B
$203K ﹤0.01%
14,635
-5,239
-26% -$82.4K
FRO icon
1878
Frontline
FRO
$8.75B
$203K ﹤0.01%
23,070
-3,029
-12% -$24K
RLMD icon
1879
Relmada Therapeutics
RLMD
$544M
$203K ﹤0.01%
+7,526
New +$156K
VNDA icon
1880
Vanda Pharmaceuticals
VNDA
$312M
$203K ﹤0.01%
18,001
-3,557
-16% -$46.8K
JRVR icon
1881
James River Group Holdings
JRVR
$218M
$202K ﹤0.01%
8,168
-1,001
-11% -$25.6K
LEGN icon
1882
Legend Biotech
LEGN
$4.3B
$202K ﹤0.01%
5,565
-702
-11% -$27.7K
PBI icon
1883
Pitney Bowes
PBI
$2.42B
$202K ﹤0.01%
38,851
-4,846
-11% -$26.3K
SAGE
1884
DELISTED
Sage Therapeutics
SAGE
$202K ﹤0.01%
6,111
-2,184
-26% -$82.1K
UMH
1885
UMH Properties
UMH
$1.32B
$202K ﹤0.01%
8,229
-1,043
-11% -$25.1K
GCO icon
1886
Genesco
GCO
$396M
$201K ﹤0.01%
3,162
-516
-14% -$33.6K
OLLI icon
1887
Ollie's Bargain Outlet
OLLI
$4.01B
$201K ﹤0.01%
4,691
-1,068
-19% -$47.7K
ARQT icon
1888
Arcutis Biotherapeutics
ARQT
$3.42B
$200K ﹤0.01%
10,401
-2,726
-21% -$46.1K
PMVP icon
1889
PMV Pharmaceuticals
PMVP
$66.1M
$200K ﹤0.01%
9,614
-2,506
-21% -$44.2K
UBER icon
1890
Uber
UBER
$134B
$200K ﹤0.01%
5,618
-2,634
-32% -$94.7K
CSII
1891
DELISTED
Cardiovascular Systems, Inc.
CSII
$200K ﹤0.01%
+8,859
New +$172K
RADI
1892
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$199K ﹤0.01%
13,907
+700
+5% +$9.76K
AVYA
1893
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$198K ﹤0.01%
15,666
-2,378
-13% -$37K
CTKB icon
1894
Cytek Biosciences
CTKB
$576M
$197K ﹤0.01%
+18,306
New +$247K
HLIT icon
1895
Harmonic Inc
HLIT
$1.21B
$196K ﹤0.01%
21,177
-2,399
-10% -$23.5K
DCH
1896
Dauch Corp
DCH
$1.3B
$195K ﹤0.01%
25,164
-3,144
-11% -$26.8K
SUMO
1897
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$195K ﹤0.01%
16,669
-2,487
-13% -$28.8K
RXT icon
1898
Rackspace Technology
RXT
$1B
$194K ﹤0.01%
17,493
-735
-4% -$8.68K
GGRP
1899
Glimpse Group
GGRP
$19M
$193K ﹤0.01%
+30,254
New +$246K
SCS
1900
DELISTED
Steelcase
SCS
$192K ﹤0.01%
16,057
-2,947
-16% -$35.6K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.